On the 22nd, Kobayashi Pharmaceutical Co., Ltd., a well-known Japanese pharmaceutical company, said that some consumers who took the company's health products containing red yeast rice ingredients have recently developed symptoms caused by kidney disease and other diseases. In view of this situation, the company has decided to recall three products that contain the relevant ingredients.
Financial Channel Special Reporter Li Qianwen: On the 22nd, Xiaolin Pharmaceutical announced on its official website that some consumers who took the company's health products containing red yeast rice ingredients have recently developed symptoms such as kidney disease. According to Japanese media reports, since January this year, 13 consumers have been reported to be unwell, of which 6 are hospitalized, and some patients even need dialysis.
Kobayashi Pharmaceutical said that after analyzing the composition of red yeast rice health products, it was found that some of the red yeast rice raw materials may contain unknown ingredients beyond the company's grasp. At present, it is still inconclusive whether there is a correlation between this unknown ingredient and consumers' illness, but in order to prevent the further expansion of the damage to consumers' health, Kobayashi Pharmaceutical has decided to recall three products containing red yeast rice and call on consumers to immediately stop taking these three products. According to Japanese media reports, the number of recalls is as high as about 300,000 copies.
On the evening of the 22nd, the president of Kobayashi Pharmaceutical held a press conference to bow and apologize for the issue. Japanese media reported that the results of the analysis on the 16th of this month showed that it may contain unknown ingredients, but the company did not announce a recall until the 22nd, in which the president of Kobayashi Pharmaceutical admitted that the decision was slow.
Kobayashi Pharmaceutical is a long-established Japanese pharmaceutical company with a history of more than 100 years, and its regular medicines, such as liquid band-aids and children's antipyretic patches, are also popular among tourists visiting Japan. The health products related to this recall were previously sold in many drugstores in Japan, so the possibility that some visitors to Japan may be able to buy the related products. In addition, some domestic e-commerce websites are still selling related products, and consumers who have purchased similar health products are reminded to confirm as soon as possible and immediately stop taking the products that have been recalled by the manufacturer.
Source | CCTV Finance